NCT02626728

Brief Summary

Most recently, the Transanal Minimally Invasive Surgery (TAMIS) approach combined with single-port technology has allowed that pelvic surgery can be laparoendocopically performed from both its abdominal and perineal aspects.Previously, a strong negative association between medium- and long-term survival and male gender with narrow pelvis have been reported. TAMIS has a significant potantial for improving the quality of the surgical resection of rectal tumors in men with visceral obesity and narrow pelvis. This group of patients have also a high rate of conversion to open surgery. Focusing on improvement in intraoperative conditions and surgical techniques rather than routine conventional procedures may be the way to go concerning favorable short- and long-term outcomes. The selection of adequate surgical approach to the high-risk patients with visceral obesity and a bulky mesentery may prevent or limit the risk for anastomotic leakage and improve oncologic margin clearence. This is a prospective observational feasability study of the TAMIS-procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 10, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 22, 2016

Status Verified

November 1, 2016

Enrollment Period

1 year

First QC Date

December 8, 2015

Last Update Submit

November 21, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • morbidity

    Clavien-Dindo

    30-days

Secondary Outcomes (2)

  • mortality

    30-days

  • short-term oncological result

    30-days

Interventions

all patients included recieve laparoscopic assisted transanal minimally invasive surgery

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with a solitary rectal cancer, who is eligible for surgery. Patients with rectal cancer (T1-3 stages verified by MRI), regardless regional lymph-node status and distant metastasis, will be offered the operative procedure with TAMIS technique.

You may qualify if:

  • rectal cancer with histological diagnosis
  • tumors located between 10 - 4 cm from the anal verge measured with a rigid rectoscope.
  • suitable for elective resection

You may not qualify if:

  • preoperative magnetic resonance imaging (MRI) showing diameter of tumor size \>6 cm
  • American Society of Anesthesiologists (ASA) class IV and V
  • anticipated need of intensive care unit (ICU)
  • history of previous major abdominal surgery
  • computer assisted tomography (CT) or MRI evidence of tumor infiltration of adjacent organs
  • obese patient with body mass index \>35kg/m2
  • those, who do not understand the requirements of the protocol
  • pregnancy
  • more than one colorectal tumor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre Hospital University of Copenhagen

Hvidovre, 2650, Denmark

Location

MeSH Terms

Conditions

Rectal Neoplasms

Interventions

Transanal Endoscopic Surgery

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Natural Orifice Endoscopic SurgeryEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisProctoscopyEndoscopy, GastrointestinalEndoscopy, Digestive SystemDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Mette W Christoffersen, M.D, PhD

    Hvidovre Hospital University of Copenhagen

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D, PhD

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 10, 2015

Study Start

September 1, 2015

Primary Completion

September 1, 2016

Study Completion

October 1, 2016

Last Updated

November 22, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations